Oncology nurses “play a pivotal role in guiding patients” through the genetic testing process, an expert explained.
The FDA received a biologics license application for accelerated approval of RP1 plus nivolumab for advanced, pretreated ...
The FDA accepted a supplemental new drug application to darolutamide plus androgen deprivation therapy for metastatic hormone-sensitive prostate cancer. The FDA accepted a supplemental new drug ...
Novel Drug Combo Is Promising for PD-L1-Resistant Solid Cancers ...
Novel Drug Combo Is Promising for PD-L1-Resistant Solid Cancers ...
The FDA granted an accelerated approval to zanidatamab-hrii for previously treated, unresectable or metastatic HER2-positve ...
The FDA granted a fast track designation to ALE-P02 for patients with CLDN1-positive squamous solid tumors. The FDA granted ...
Clinicians should consider a rapid taper approach for patients with cancer who exhibit repeated signs of opioid misuse, an ...
Novel Drug Combo Is Promising for PD-L1-Resistant Solid Cancers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback